BridgeMD
New treatment option for Lower Resp Tract Infection
Official title Effect of Pediatric Lung Ultrasound on Antibiotic Prescriptions in Hospitalized Children and Adolescents With Lower Respiratory Tract Infections. A Randomized Controlled Trial.
ClinicalTrials.gov ID: NCT06876766
What this study is testing
- What it's testing
- Title: Effect of Pediatric Lung Ultrasound on Antibiotic Prescriptions in Hospitalized Children and Adolescents with Lower Respiratory Tract Infections (PLUS-AP Trial) Purpose of the Study: This study is being done to find out if a type of imaging called lung ultrasound (LUS) can help doctors decide when to stop antibiotics in children and teens who are in the hospital with lung infections, like pneumonia. Antibiotics are often given to these patients, but sometimes they are used for longer than necessary, which can be harmful.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 18
You may be able to join if
- Age between 3 months and 17 years old inclusive
- Currently admitted to the pediatric Ward or boarding in the Emergency Department within 24 hours of admission order due to lower respiratory tract...
You likely can't join if
- Sickle cell disease (SCD).
- On chemotherapy or any other immunosuppressive therapy except systemic corticosteroids use of ≤ 5 days duration.
- Cystic fibrosis and other chronic lung diseases except asthma
- Pre-existing and/or congenital neurologic, metabolic, and cardiac conditions
- Hospitalized within the previous month
- Patients with suspected foreign body aspiration -Received antibiotic therapy within the previous week
See the full eligibility criteria
- Age between 3 months and 17 years old inclusive
- Currently admitted to the pediatric Ward or boarding in the Emergency Department within 24 hours of admission order due to lower respiratory tract infections.
- Sickle cell disease (SCD).
- On chemotherapy or any other immunosuppressive therapy except systemic corticosteroids use of ≤ 5 days duration.
- Cystic fibrosis and other chronic lung diseases except asthma
- Pre-existing and/or congenital neurologic, metabolic, and cardiac conditions
- Hospitalized within the previous month
- Patients with suspected foreign body aspiration -Received antibiotic therapy within the previous week
- Patients admitted under PI's care
The study team makes the final eligibility decision.
Where it's taking place
- Beirut, Lebanon
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 months to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beirut, Lebanon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.